drugset / Trial / NCT04464070

Pathways of Eicosanoid Metabolism

NCT04464070

Phase 0 Enrolling by invitation 10 enrolled Vanderbilt University Vanderbilt University Medical Center · collab
Non-randomizedSequentialOpen-labelBasic science

Summary

Prostaglandins are important signaling compounds formed from arachidonic acid. The enzymes that form prostaglandins, cyclooxygenase-1 and -2 are the targets of non-steroidal anti-inflammatory drugs (NSAIDs). Because prostaglandins are very unstable in the body, they can not be measured directly. Instead, their metabolites are isolated from urine or blood and quantified as markers of formation of the parent, active compounds. The investigators are testing the hypothesis that there is a previously unrecognized metabolic pathway between two prostaglandins. The investigators hypothesize that prostaglandin D2 (PGD2), in addition to its known metabolism to PGD-M, is also metabolized to 11-dehydro-thromboxane B2 (11-dehydro-TxB2).

Timeline

Start
2020-08-15
Primary completion
2027-07-30
Completion
2027-08-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule 81 mg Oral
Subject Aspirin Small molecule 325 mg Oral

Indications

No indication recorded.